These effects, along with a previous report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 help the strategy of targeting ACKR3 as a novel way to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-related disorders. These outcomes suggest that conolidine https://francisu333ugq9.laowaiblog.com/profile